Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Davidson Kempner and 2 Investors Disclose Positions in Quartet Merger Corp

The blank check company Quartet Merger Corp (NASDAQ:QTETU) went public on October 30th. Three funds have already disclosed holding  shares of the company, one of which being Davidson Kempner, managed by Thomas Lenox Kempner. The fund reported a 7.13% stake, which amasses 810,000 shares.


Bulldog Investors disclosed owning  an aggregate amount of 700,000 shares, which represent 6.34% of the common stock. Polar Securities’ stake is the largest of all three and amasses 1.6 million shares, equal to 12.62% of Quartet’s common stock.

Disclosure: none

Recommended Reading:

Mason Hawkins, Southeastern Initiate Stake in Empire State Realty Trust; Decrease Position in Aon Plc

Steve Cohen, SAC Capital Reveal 5.3% Stake in Intercept Pharmaceuticals

Karpus Management Ups Stakes in Zweig Total Return Fund and Western Asset Inflation Management Fund

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.